CALGARY, Sept. 14 /CNW/ - The Board of Directors of Epicore BioNetworks Inc. is pleased to announce that the Company has acquired ownership of its main business site in Eastampton, New Jersey, USA. Since the Company's inception Epicore's research and manufacturing have been conducted in Eastampton. Since 1999 corporate management and marketing operations have been centered at the site. During this period the Company leased the facility. The Company formed a limited liability realty partnership with an adjacent business to purchase the combined site for US$1.4 million. Financing was secured from Epicore's main US bank, Wachovia. The acquisition provides security for Epicore operations and offers operating costs savings. The acquisition is supported by Epicore's growing and profitable international aquaculture business. Further, the acquisition is key to the Company's plans to expand its North American business in the environmental market. Epicore BioNetworks Inc. announces that it has granted stock options to directors and employees of the company. The number of options granted is 992,500, which is equivalent to 4.2% of Epicore's issued common stock. Under the terms of the Epicore Stock Option Plan, options may be issued from time to time in any amount up to 10% of the issued and outstanding Epicore common shares. These options have an exercise price of $0.10 and expire in five years. The grant to directors follows Company board compensation policy. The grant includes additional options to Mr. D'Addario, who has agreed to lead a new company division that will develop business for the company in the environmental field. This role is in addition to his regular board duties. The grant is subject to the receipt of the approval of the TSX Venture Exchange. Epicore BioNetworks Inc. is a leading producer of environmental biotechnology and animal nutrition products. It manufactures in the USA and markets worldwide to a variety of industries to reduce environmental pollution and increase operational productivity. Epicore is a major supplier to the shrimp aquaculture industry. Epicore BioNetworks Inc. is a public corporation with a registered office in Calgary, Alberta, Canada and with shares listed on the Canadian Venture Exchange (symbol EBN). (The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.)
Epicore Acquires Eastampton Site
Epicore BioNetworks Inc on 6ix
Earlier from Epicore BioNetworks
- Epicore Appoints New Director
- Epicore 2006 Third Quarter Results
- Epicore 2006 Second Quarter Results for the period ended 31 December 2005; currency in US Dollars
- Epicore 2006 First Quarter Results for the period ended 30 September 2005; currency in US Dollars
- Epicore BioNetworks Inc. Fiscal Year 2005 Results for the period ended 30 June 2005
Later from Epicore BioNetworks
- Epicore Signs Letter of Intent with IONA Contractors Ltd.
- Epicore BioNetworks Inc. Fiscal Year 2006 Results for the period ended 30 June 2006
- Epicore BioNetworks Inc. Abandons IONA Acquisition
- Epicore BioNetworks Inc. Announces Board Director Change
- Epicore 2007 First Quarter Results for the period ended 30 September 2006; currency in US Dollars
Follow Epicore BioNetworks into a list and get an email when it puts out news.
Follow Epicore BioNetworks